ABVC BioPharma, Inc.
ABVC
$1.00
-$0.06-5.74%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -79.18% | -6.81% | 138.20% | 23.54% | 126.75% |
| Total Receivables | -88.34% | -63.45% | -33.91% | 121.53% | 11.97% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -22.26% | 159.34% | 260.29% | 389.92% | 93.45% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 4.89% | 4.63% | 11.25% |
| Total Current Assets | -85.14% | -55.85% | 14.75% | 89.57% | 26.53% |
|
|
|||||
| Total Current Assets | -85.14% | -55.85% | 14.75% | 89.57% | 26.53% |
| Net Property, Plant & Equipment | 68.03% | 68.35% | 1,180.83% | 47.23% | 1.62% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.77% | 33.13% | -0.83% | 25.45% | 27.93% |
| Total Assets | 19.45% | 32.65% | 179.34% | 46.42% | 10.98% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 1.12% | 4.44% | 8.39% | -4.29% | -6.35% |
| Short-term Debt | -75.08% | -93.51% | -48.32% | 56.69% | 27.08% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 66.42% | -15.72% | -25.35% | -61.79% | -52.98% |
| Total Finance Division Other Current Liabilities | -24.76% | 2.30% | 68.73% | 117.10% | 94.59% |
| Total Other Current Liabilities | -24.76% | 2.30% | 68.73% | 117.10% | 94.59% |
| Total Current Liabilities | -12.83% | -19.87% | -6.00% | 3.04% | -0.25% |
|
|
|||||
| Total Current Liabilities | -12.83% | -19.87% | -6.00% | 3.04% | -0.25% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -75.08% | -93.51% | -48.32% | 56.69% | 27.08% |
| Capital Leases | 693.62% | 804.73% | 575.97% | 15.40% | -22.60% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -25.18% | -- | -- | -53.31% | 50.54% |
| Total Liabilities | 5.63% | -0.22% | 13.92% | 3.09% | -0.79% |
|
|
|||||
| Common Stock & APIC | 13.14% | 16.20% | 22.17% | 6.66% | -0.80% |
| Retained Earnings | -9.86% | -12.36% | -11.47% | -3.89% | -2.39% |
| Treasury Stock & Other | -13.24% | 5.30% | 4.39% | 7.42% | 13.04% |
| Total Common Equity | 46.68% | 99.33% | 806.28% | 44.26% | -15.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 46.68% | 99.33% | 806.28% | 44.26% | -15.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -19.94% | -19.44% | 535.21% | 742.34% | 632.27% |
| Total Equity | 29.29% | 61.24% | 1,736.67% | 81.63% | 21.22% |
|
|
|||||